GH Research PLC Ordinary Shares
GHRS •
Buy Open
Signal type
Buy
Status
Open
Open Price
$16.40
Stop Loss
$14.63
Performance
2.29%
Days Open
2
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 13, 2026
Open Price $16.40
Stop Loss $14.63
Timespan Day
Company Profile
Name GH Research PLC Ordinary Shares
Ticker GHRS
Market Cap $789.01M
Sector
Latest Close $16.77
List Date Jun 25, 2021
Description
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Website Open Company Website